These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 17693049

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma.
    Piras F, Murtas D, Minerba L, Ugalde J, Floris C, Maxia C, Colombari R, Perra MT, Sirigu P.
    Histopathology; 2007 Jun; 50(7):835-42. PubMed ID: 17543072
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung.
    Ikehara M, Oshita F, Kameda Y, Ito H, Ohgane N, Suzuki R, Saito H, Yamada K, Noda K, Mitsuda A.
    Oncol Rep; 2002 Jun; 9(4):835-8. PubMed ID: 12066218
    [Abstract] [Full Text] [Related]

  • 30. Survivin expression as a strong indicator of recurrence in urothelial bladder cancer. Predictive value of nuclear versus cytoplasmic staining.
    Skagias L, Politi E, Karameris A, Sambaziotis D, Archondakis A, Ntinis A, Moreas I, Vasou O, Koutselini H, Patsouris E.
    Anticancer Res; 2009 Oct; 29(10):4163-7. PubMed ID: 19846967
    [Abstract] [Full Text] [Related]

  • 31. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
    Mainou-Fowler T, Overman LM, Dignum H, Wood K, Crosier S, Angus B, Proctor SJ, Anderson JJ.
    Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
    Timotheadou E, Skarlos DV, Samantas E, Papadopoulos S, Murray S, Skrickova J, Christodoulou C, Papakostantinou C, Pectasides D, Papakostas P, Kaplanova J, Vrettou E, Karina M, Kosmidis P, Fountzilas G.
    Anticancer Res; 2007 Jan; 27(6C):4481-9. PubMed ID: 18214064
    [Abstract] [Full Text] [Related]

  • 33. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 34. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
    Lin CY, Hung HC, Kuo RC, Chiang CP, Kuo MY.
    Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
    [Abstract] [Full Text] [Related]

  • 35. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
    Miao LJ, Wang J, Li SS, Wu YM, Wu YJ, Wang XC.
    Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
    [Abstract] [Full Text] [Related]

  • 36. Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications.
    Mohamed S, Yasufuku K, Nakajima T, Hiroshima K, Chiyo M, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Agamy G, El-Shahhat H, Fujisawa T, Yoshino I.
    Eur Respir J; 2009 Jan; 33(1):127-33. PubMed ID: 18715879
    [Abstract] [Full Text] [Related]

  • 37. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [Abstract] [Full Text] [Related]

  • 38. Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer.
    Keum JS, Kong G, Yang SC, Shin DH, Park SS, Lee JH, Lee JD.
    Br J Cancer; 1999 Sep; 81(1):127-32. PubMed ID: 10487623
    [Abstract] [Full Text] [Related]

  • 39. Prognostic impact of Deoxyribonucleic acid (DNA) image analysis cytometry and immunohistochemical expression of Ki67 in surgically resected non-small cell lung cancers.
    Maounis NF, Chorti M, Apostolakis E, Ellina E, Blana A, Aggelidou M, Dritsas I, Markidou S.
    Cancer Detect Prev; 2006 Sep; 30(6):507-14. PubMed ID: 17113721
    [Abstract] [Full Text] [Related]

  • 40. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T, Nakagawa K, Nakamura H, Takada Y, Matsui K, Kawahara K.
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.